TERT structural rearrangements in metastatic pheochromocytomas

  1. Richard W Tothill5,9,10
  1. 1Cancer Genetics, Kolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia
  2. 2The University of Sydney, Sydney, New South Wales, Australia
  3. 3The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen N, Denmark
  4. 4Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark
  5. 5The Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
  6. 6Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
  7. 7Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
  8. 8Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
  9. 9The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
  10. 10The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
  11. 11The Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia
  12. 12Cancer Diagnosis and Pathology Group, Kolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia
  13. 13School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia
  1. Correspondence should be addressed to T Dwight or R Tothill: trisha.dwight{at}sydney.edu.au or rtothill{at}unimelb.edu.au
  1. Figure 1

    TERT expression in PC/PGL (n = 39) taken from RNA-seq data described in Flynn et al. (2015). (A) Square root of RNA-seq counts per million aligned to the TERT locus in 39 PC/PGL tumor samples. (B) Sashimi plot depicting mapped RNA-seq reads spanning TERT exons 6–9 (supporting read number shown in exon links) and read depth (maximum range shown in parenthesis). Exons 7–8 are spliced out in β-deletion (β.) isoform.

  2. Figure 2

    Structural alterations involving the TERT promoter identified in metastatic pheochromocytomas. (A) Circos plots displaying global somatic copy-number and breakpoints detected by WGS analysis across the three TERT overexpressing PC tumors. No somatic breakpoints were detected in V-PH-01T. Chromosome ideograms displayed as outer ring, somatic copy-number changes detected as inner ring. Green line indicates neutral (diploid) or copy-number gain from segmentation, and red line indicates copy-number loss. Inner lines show detected breakpoints. Red lines highlight the validated TERT promoter rearrangements. Data for chrX and chrY not shown. (B) Chromosome level view of somatic copy-number alterations and breakpoints in V-PH-03T highlighting an intra-chromosomal deletion detected proximal to TERT as indicated by red line. (C) Sanger sequencing validation of 4.3 Mb deletion upstream of TERT in V-PH-03T. (D) Chromosome level view of somatic copy-number alterations and breakpoints in V-PH-04T involving chr5p and chr22q. Red line indicates TERT proximal breakpoint. (E) Sanger sequencing validation of non-reciprocal translocation (t(5;22)(p15.3;q12.3)) identified in V-PH-04T. Arrows in panels C and E indicates TERT proximal structural breakpoint previously described in aggressive neuroblastoma (Peifer et al. 2015).

  3. Figure 3

    Structural rearrangements juxtapose TERT proximal to active enhancers in metastatic PC. The potential for enhancer-driven activation of TERT was assessed using dbSUPER (an integrative database of super-enhancers; Khan & Zhang 2016). Candidate super-enhancers are based on H3K27ac signals from normal adult adrenal tissue (GEO accession: GSM1013168). ENCODE data for H3K27ac (blue track) and DNase hypersensitivity (green track) in fetal adrenal tissue supporting super-enhancer features was accessed through UCSC browser (build hg19) (Rosenbloom et al. 2013). (A) The 4.3 Mb somatic deletion observed in V-PH-03T is predicted to result in placement of a super-enhancer 1.1 Mb from the TERT TSS (SE_01397, dbSUPER). (B) The somatic non-reciprocal translocation, t(5;22)(p15.3;q12.3), identified in V-PH-04T is predicted to result in the placement of a super-enhancer 1.9 Mb from the TERT TSS (SE_01144, dbSUPER).

| Table of Contents